Outcomes following treatment of metastatic spine tumors.
Fifty seven consecutive patients with metastatic spine tumors were assessed for their suitability for operative treatment or radiotherapy and/or chemotherapy using a modified version of the Nihon University scoring system. Using this scoring system 29 patients underwent surgery and 28 received radiotherapy/chemotherapy. The outcomes were assessed to determine if a modified scoring had any effect on patient survival. No statistical difference was found between the two groups, though a trend was noted--the group receiving surgery had a mean survival of 30 weeks compared to a mean survival of 16 weeks found in the non-surgical group.
Day
G A
GA
Division of Orthopaedic Surgery, University of Queensland, Australia.
McPhee
I B
IB
Swanson
C
C
Tomlinson
F H
FH
McCombe
P
P
Coyne
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D013125:Spinal Neoplasms / Q000556:secondary* / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome